Related Experiment Video

Updated: May 3, 2026

Direct Drug Delivery to Kidney via the Renal Artery
11:18

Direct Drug Delivery to Kidney via the Renal Artery

Published on: April 17, 2021

8.3K

Implementation of clinical pharmacy services in a pediatric dialysis unit

Radwa El Borolossy1, Lamia El Wakeel, Ihab El Hakim

  • 1Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, 4 street 292, New Maadi, New Maadi, Cairo, Egypt, radwa.maher14@yahoo.com.

Pediatric Nephrology (Berlin, Germany)
|February 18, 2014
PubMed

Insights

Clinical pharmacist interventions significantly improved blood pressure, mineral levels, and treatment satisfaction in pediatric hemodialysis patients. This pharmaceutical care enhanced biochemical markers and patient well-being.

Area of Science:

  • Nephrology
  • Clinical Pharmacy
  • Pediatric Medicine

Background:

  • Patients with end-stage renal disease (ESRD) on hemodialysis often have complex medication regimens, increasing their risk of drug therapy-related problems (DTRPs).
  • Children undergoing hemodialysis are particularly vulnerable to DTRPs due to intricate treatment plans.

Purpose of the Study:

  • To identify DTRPs in pediatric hemodialysis patients.
  • To evaluate the impact of clinical pharmacist interventions on the outcomes of these patients.

Main Methods:

  • A 9-month study involving 50 pediatric hemodialysis outpatients divided into control and test groups.
  • The test group received thrice-weekly pharmaceutical care alongside usual medical care, while the control group received only usual care.

Main Results:

  • The test group demonstrated significant reductions in systolic and diastolic blood pressure, serum phosphorus, and parathyroid hormone levels.
  • Serum calcium and calcium-x-phosphorus product levels improved significantly in the test group compared to the control.
  • Patient satisfaction with renal treatment markedly increased in the test group.

Conclusions:

  • Pharmacist-led pharmaceutical care interventions positively impacted biochemical parameters in pediatric hemodialysis patients.
  • These interventions led to enhanced patient satisfaction and improved clinical outcomes.
Abstract

More Related Videos

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.9K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
1.6K